Diabetes
| T2D & GLP-1 RA
Diabetes
T2D & GLP-1 RA
Efficacy and safety of GLP1RAs in liver-transplanted patients with diabetes: a 12 months follow up evaluation
book_2
Source:
EASD 2023 - Short Oral Session
calendar_today
Published on Medfyle:
October 2023
In this medfyle
There is a lack of data regarding GLP- 1 RAs in patients with liver transplant and diabetes. Over a period of 12 months, this study showed that GLP-1 RAs can be considered safe and effective in these patients.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
This is a summary of a presentation given at the EASD 2023 Annual Meeting. The content is developed by Infomedica in collaboration with the Diabetes Education Study Group (DESG).
The information and data provided is for information purposes only. The presenting author(s) of the original presentation had no involvement in the creation of this content. The viewpoints expressed may not represent Infomedica, Medfyle, or the DESG.
©2023 Infomedica-Medfyle. All rights reserved.
